- Home
- Publications
- Publication Search
- Publication Details
Title
Nephrotoxicity of anticancer treatment
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages gfw338
Publisher
Oxford University Press (OUP)
Online
2016-10-07
DOI
10.1093/ndt/gfw338
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients
- (2016) Anushree C. Shirali et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cardiotoxicity of anthracycline therapy: current perspectives
- (2016) Mihaela Valcovici et al. Archives of Medical Science
- Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors
- (2016) Ko Sato et al. BMC CANCER
- Validity of new methods to evaluate renal function in cancer patients treated with cisplatin
- (2016) Yohei Funakoshi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Long-Term Renal Outcomes after Cisplatin Treatment
- (2016) S. Latcha et al. Clinical Journal of the American Society of Nephrology
- Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System
- (2016) Kenar D. Jhaveri et al. KIDNEY INTERNATIONAL
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
- (2016) Frank B. Cortazar et al. KIDNEY INTERNATIONAL
- Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
- (2016) Asher Chanan-Khan et al. LANCET ONCOLOGY
- Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)
- (2015) V. Launay-Vacher et al. ANNALS OF ONCOLOGY
- Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma
- (2015) François-Xavier Nouhaud et al. ANTI-CANCER DRUGS
- The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab
- (2015) Joanna Huszno et al. Archives of Medical Science
- Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature
- (2015) Ning Jia et al. BMC CANCER
- Hypocalcaemia in patients with metastatic bone disease treated with denosumab
- (2015) Jean-Jacques Body et al. EUROPEAN JOURNAL OF CANCER
- Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD
- (2015) R. Torres et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New drug toxicities in the onco-nephrology world
- (2015) Mark A. Perazella et al. KIDNEY INTERNATIONAL
- Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
- (2015) Nick Thatcher et al. LANCET ONCOLOGY
- A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use
- (2015) Phylicia Baird et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
- (2015) Kenar D. Jhaveri et al. JAMA Oncology
- Side Effects of Bone-Targeted Therapies in Advanced Breast Cancer
- (2014) Christoph Domschke et al. Breast Care
- Acute renal failure associated with the new BRAF inhibitor vemurafenib: A case series of 8 patients
- (2014) Vincent Launay-Vacher et al. CANCER
- Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature
- (2014) Joichi Usui et al. HUMAN PATHOLOGY
- Kidney injuries related to ipilimumab
- (2014) Hassane Izzedine et al. INVESTIGATIONAL NEW DRUGS
- Denosumab for Treatment of Hypercalcemia of Malignancy
- (2014) Mimi I. Hu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pemetrexed induced acute kidney injury in patients with non-small cell lung cancer: reversible and chronic renal damage
- (2014) Giuseppe Rombolà et al. JOURNAL OF NEPHROLOGY
- Crizotinib Effects on Creatinine and Non-Creatinine–Based Measures of Glomerular Filtration Rate
- (2014) D. Ross Camidge et al. Journal of Thoracic Oncology
- Carfilzomib-Associated Tumor Lysis Syndrome
- (2014) Ryan N. Shely et al. PHARMACOTHERAPY
- Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma
- (2014) Liliane Hobeika et al. BMC Nephrology
- Glomerular Diseases Associated With Cancer, Chemotherapy, and Hematopoietic Stem Cell Transplantation
- (2013) Kenar D. Jhaveri et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib
- (2013) Evelyn M. Brosnan et al. CANCER
- Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium
- (2013) John D. Hainsworth et al. CANCER INVESTIGATION
- Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series
- (2013) Frederico Leal et al. JOURNAL OF CHEMOTHERAPY
- Nephrology Crossword: Onco-nephrology—chemotherapy agents and nephrotoxicity
- (2013) Kenar D. Jhaveri et al. KIDNEY INTERNATIONAL
- Glomerular diseases seen with cancer and chemotherapy: a narrative review
- (2013) Kenar D. Jhaveri et al. KIDNEY INTERNATIONAL
- Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
- (2013) A Z Badros et al. LEUKEMIA
- Acute kidney injury following crizotinib administration for non-small-cell lung carcinoma
- (2013) Lauris Gastaud et al. LUNG CANCER
- All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study
- (2013) C. Vigneau et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- An Unusual Case of Abdominal Pain
- (2013) Russell Goodman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- (2013) Caroline J. Voskens et al. PLoS One
- Targeting the BRAF V600E Mutation in Multiple Myeloma
- (2013) M. Andrulis et al. Cancer Discovery
- Clofarabine-induced kidney toxicity
- (2013) Kenar D Jhaveri et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project
- (2013) Beatrice J. Edwards et al. Journal of Oncology Practice
- Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents
- (2012) M. A. Perazella Clinical Journal of the American Society of Nephrology
- Long term renal toxicity of ifosfamide in adult patients – 5year data
- (2012) James K. Farry et al. EUROPEAN JOURNAL OF CANCER
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer
- (2012) Giulia Russo et al. Internal and Emergency Medicine
- Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology
- (2012) Adriana Albini et al. Internal and Emergency Medicine
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kidney Tubular Toxicity of Maintenance Pemetrexed Therapy
- (2011) Ilya G. Glezerman et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma
- (2011) Yoshihiko Tomita et al. EUROPEAN JOURNAL OF CANCER
- The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Resolution of Severe Ipilimumab-Induced Hepatitis After Antithymocyte Globulin Therapy
- (2011) Katarzyna D. Chmiel et al. JOURNAL OF CLINICAL ONCOLOGY
- The Tumor Lysis Syndrome
- (2011) Scott C. Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bisphosphonates in Breast Cancer Patients with Bone Metastases
- (2010) Ingo J. Diel Breast Care
- Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
- (2010) Mitchell S. Cairo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Bruce G. Robinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial
- (2010) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
- (2010) S. Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lenalidomide-Induced Acute Interstitial Nephritis
- (2010) E. J. Lipson et al. ONCOLOGIST
- Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed
- (2010) Aristeidis Stavroulopoulos et al. RENAL FAILURE
- Understanding and managing the possible adverse effects associated with bevacizumab
- (2009) S. S. Shord et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
- (2009) Hassane Izzedine et al. EUROPEAN JOURNAL OF CANCER
- Thrombotic microangiopathy associated with gemcitabine: rare but real
- (2009) M Wasif Saif et al. Expert Opinion On Drug Safety
- Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
- (2009) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Anti-CTLA4 Antibody–Induced Lupus Nephritis
- (2009) Fouad Fadel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temsirolimus-Induced Glomerulopathy
- (2009) Hassane Izzedine et al. ONCOLOGY
- Renal toxicity of targeted therapies
- (2009) Ronan J. Kelly et al. Targeted Oncology
- Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis
- (2008) Xiaolei Zhu et al. ACTA ONCOLOGICA
- Hypertension and proteinuria: a class-effect of antiangiogenic therapies
- (2008) Vincent Launay-Vacher et al. ANTI-CANCER DRUGS
- A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2008) S. Faderl et al. BLOOD
- Integrated Pathway Analysis of Rat Urine Metabolic Profiles and Kidney Transcriptomic Profiles To Elucidate the Systems Toxicology of Model Nephrotoxicants
- (2008) Ethan Yixun Xu et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Interaction of Cisplatin with the Human Organic Cation Transporter 2
- (2008) K. K. Filipski et al. CLINICAL CANCER RESEARCH
- A Preeclampsia-like Syndrome Characterized by Reversible Hypertension and Proteinuria Induced by the Multitargeted Kinase Inhibitors Sunitinib and Sorafenib
- (2008) T. V. Patel et al. JNCI-Journal of the National Cancer Institute
- Pathogenesis and treatment of renal failure in multiple myeloma
- (2008) M A Dimopoulos et al. LEUKEMIA
- Azotemia associated with use of lenalidomide in plasma cell dyscrasias
- (2008) Eric D. Batts et al. LEUKEMIA & LYMPHOMA
- Home Blood-Pressure Monitoring in Patients Receiving Sunitinib
- (2008) Michel Azizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started